243 related articles for article (PubMed ID: 21519797)
1. Screening for serological biomarkers of pancreatic cancer by two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry.
Wang Y; Kuramitsu Y; Yoshino S; Takashima M; Zhang X; Ueno T; Suzuki N; Oka M; Nakamura K
Oncol Rep; 2011 Jul; 26(1):287-92. PubMed ID: 21519797
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of up-regulated cofilin-1 and down-regulated cofilin-2 characteristic of pancreatic cancer tissues.
Wang Y; Kuramitsu Y; Ueno T; Suzuki N; Yoshino S; Iizuka N; Zhang X; Oka M; Nakamura K
Oncol Rep; 2011 Dec; 26(6):1595-9. PubMed ID: 21894436
[TBL] [Abstract][Full Text] [Related]
3. Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry.
Mikuriya K; Kuramitsu Y; Ryozawa S; Fujimoto M; Mori S; Oka M; Hamano K; Okita K; Sakaida I; Nakamura K
Int J Oncol; 2007 Apr; 30(4):849-55. PubMed ID: 17332923
[TBL] [Abstract][Full Text] [Related]
4. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
5. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
6. Proteomic differential display identifies upregulated vinculin as a possible biomarker of pancreatic cancer.
Wang Y; Kuramitsu Y; Ueno T; Suzuki N; Yoshino S; Iizuka N; Zhang X; Akada J; Oka M; Nakamura K
Oncol Rep; 2012 Nov; 28(5):1845-50. PubMed ID: 22940724
[TBL] [Abstract][Full Text] [Related]
7. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
8. Proteomic differential display analysis for TS-1-resistant and -sensitive pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.
Yoshida K; Kuramitsu Y; Murakami K; Ryozawa S; Taba K; Kaino S; Zhang X; Sakaida I; Nakamura K
Anticancer Res; 2011 Jun; 31(6):2103-8. PubMed ID: 21737628
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.
Pawlik TM; Hawke DH; Liu Y; Krishnamurthy S; Fritsche H; Hunt KK; Kuerer HM
BMC Cancer; 2006 Mar; 6():68. PubMed ID: 16542425
[TBL] [Abstract][Full Text] [Related]
10. Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in human scirrhous-type gastric carcinoma cells.
Kuramitsu Y; Baron B; Yoshino S; Zhang X; Tanaka T; Yashiro M; Hirakawa K; Oka M; Nakamura K
Anticancer Res; 2010 Nov; 30(11):4459-65. PubMed ID: 21115893
[TBL] [Abstract][Full Text] [Related]
11. Clinical proteomics: liquid chromatography-mass spectrometry purification systems.
Henry M; Meleady P
Methods Mol Biol; 2011; 681():473-83. PubMed ID: 20978984
[TBL] [Abstract][Full Text] [Related]
12. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of urinary exosomes in cardiovascular and associated kidney diseases by two-dimensional electrophoresis and LC-MS/MS.
Zubiri I; Vivanco F; Alvarez-Llamas G
Methods Mol Biol; 2013; 1000():209-20. PubMed ID: 23585095
[TBL] [Abstract][Full Text] [Related]
14. Advances in proteomic techniques for biomarker discovery in COPD.
Casado B; Luisetti M; Iadarola P
Expert Rev Clin Immunol; 2011 Jan; 7(1):111-23. PubMed ID: 21162654
[TBL] [Abstract][Full Text] [Related]
15. Characterization of human serum amyloid A protein isoforms separated by two-dimensional electrophoresis by liquid chromatography/electrospray ionization tandem mass spectrometry.
Ducret A; Bruun CF; Bures EJ; Marhaug G; Husby G; Aebersold R
Electrophoresis; 1996 May; 17(5):866-76. PubMed ID: 8783012
[TBL] [Abstract][Full Text] [Related]
16. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
Yin GN; Lee HW; Cho JY; Suk K
Brain Res; 2009 Apr; 1265():158-70. PubMed ID: 19368810
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
18. Staining with highly sensitive Coomassie brilliant blue SeePico™ Stain after Flamingo™ fluorescent gel stain is useful for cancer proteomic analysis by means of two-dimensional gel electrophoresis.
Kuramitsu Y; Hayashi E; Okada F; Zhang X; Tanaka T; Ueyama Y; Nakamura K
Anticancer Res; 2010 Oct; 30(10):4001-5. PubMed ID: 21036714
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of rice defense response induced by probenazole.
Lin YZ; Chen HY; Kao R; Chang SP; Chang SJ; Lai EM
Phytochemistry; 2008 Feb; 69(3):715-28. PubMed ID: 17950386
[TBL] [Abstract][Full Text] [Related]
20. Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis.
Liu W; Liu B; Cai Q; Li J; Chen X; Zhu Z
Clin Chim Acta; 2012 Jul; 413(13-14):1098-106. PubMed ID: 22446497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
